Reduced prolactin and cortisol responses to d-fenfluramine in depressed compared to healthy matched control subjects

Neuropsychopharmacology

Volumn 14, Issue 5, 1996, Pages 349-354

  Cleare, Anthony J ^a   Murray, Robin M ^a   O'Keane, Veronica ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Cortisol; d Fenfluramine; Major depression; Prolactin; Serotonin; Suicide

Indexed keywords

DEXFENFLURAMINE; HYDROCORTISONE; PROLACTIN; SEROTONIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; FEMALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; MALE; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; SEROTONINERGIC SYSTEM; SUICIDE;

EID: 0029878811     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0893-133X(95)00144-3     Document Type: Article

References (43)

1. Altomonte L, Zoli A, Alesi F, Ghirlandi G, Manna R, Greco A 1987): Effects of fenfluramine on GH and PRL secretion in obese subjects. Horm Res 27:190-194
2. American Psychiatric Association (1987): Diagnostic and Statistical Manual of Mental Disorders, ed 3, rev, Washington DC, American Psychiatric Association
3. Asnis GM, Eisenberg J, van Praag HM, Lemus CZ, Friedman JM, Miller AH (1988): The Neuroendocrine response to fenfluramine in depressives and normal controls. Biol Psychiatr 24:117-120
4. 1A receptor gene expression by dexamethasone. Neuropsychopharmacology 10:215-222
5. Checkley SA (1980): Neuroendocrine tests of monoamine function in man: A review of basic theory and its application to the study of depressive illness. Psycholog Med 10:35-53
6. Coccaro E, Siever LJ, Klar HM, Maurer G, Cochrane K, Cooper TB, Mohs RC, Davis KL (1989): Serotonergic studies in patients with affective and personality disorders. Correlates with suicidal and impulsive aggressive behavior. Arch Gen Psychiatr 46:587-599
7. Coccaro EF, Kavoussi RJ, Hauger R (1994): PRL and HVA responses to D- and D,L-fenfluramine in humans. Biol Psychiatr 35:644
8. 1A receptor sensitivity in major depression. A neuroendocrine study with buspirone. Br J Psychiatr 164:372-379
9. Deakin JFW, Pennell I, Upadhyaya AJ, Lofthouse R (1990): A neuroendocrine study of 5-HT function in depression: Evidence for biological mechanisms of endogenous and psychosocial causation. Psychopharmacology 101:85-92
10. De Kloet E, Sybesma H, Reul JMHM (1986): Selective control by corticosterone of serotonin-1 receptors capacity in raphe-hippocampal system. Neuroendocrinology 42: 513-521
11. Dinan TG (1994): Glucocorticoids and the genesis of depressive illness. Br J Psychiatr 164:365-372
12. Ecclestone D, Doogan D (1989): Serotonin and behavioural disorders. Br J Psychiatr 8(suppl):7-69
13. Feeney S, Goodall E, Silverstone T (1993): The prolactin response to d- and l-fenfluramine and to d-amphetamine in human subjects. Int Clin Psychopharmacol 8:49-54
14. Garattini S, Mennini T, Samanin, R (1987): From fenfluramine racemate to d-fenfluramine. Ann N Y Acad Sci 499:156-166
15. 2 receptors. Eur J Pharmacol 179:103-109
16. Goodall EM, Cowen J, Franklin M, Silverstone T (1993): Ritanserin attenuates anorectic, endocrine and thermic responses to d-fenfluramine in human volunteers. Psychopharmacology 112:461-166
17. Gorard TM, Taylor TM, Medbak LA, Perry LA, Libby GW, Farthing MJG (1993): Plasma prolactin, adrenocorticotrophic hormone and cortisol after administration of d-fenfluramine or placebo to healthy subjects. Int Clin Psychopharmacol 8:123-128
18. Gudelsky GA, Simonovic M, Meltzer HY (1984): Dopaminergic and serotonergic control of neuroendocrine function. Monographs in Neural Sciences 10:85-102
19. Hamilton M (1960): A rating scale for depression. J Neurol Neurosurg Psychiatr 23:56-62
20. Hollander E, Cohen LJ, DeCaria C, Saoud JB, Stein DJ, Cooper TB, Islam NN, Liebowitz MR, Klein DF (1993): Timing of neuroendocrine responses and effect of m-CPP and fenfluramine plasma levels in OCD. Biol Psychiatr 34: 407-413
21. Invernizzi R, Berettera C, Garratini S, Samanin R (1986): D- and L-isomers of fenfluramine differ markedly in their interaction with brain serotonin and catecholamines in the rat. Eur J Pharmacolo 120:9-15
22. 1A receptor activation: Effect of 5-HT receptor and beta-adrenoceptor antagonists. J Clin Endocrinol Metab 70:670-674
23. 1A receptor responsivity in unipolar depression: Evaluation of ipsapirone-induced ACTH and cortisol secretion in patients and controls. Biol Psychiatr 28:620-628
24. Lichtenberg P, Shapira B, Gillon D; Kindler S, Cooper TB, Newman ME, Lerer B (1992): Hormone responses to fenfluramine and placebo challenge in endogenous depression. Psychiatry Res 43:137-146
25. Lopez-Ibor JJ Jr, Saiz Ruiz J, Iglesias M (1988): The fenfluramine challenge test in the affective spectrum: A possible marker of endogenicity and severity. Pharmacopsychiatry 21:9-14
26. Maes M, Meltzer HY (1995): The serotonin hypothesis of major depression. In Bloom FE, Kupfer DJ (eds), Psychopharmacology, the Fourth Generation of Progress, New York, Raven, pp 933-944
27. Maes M, D'Hondt P, Suy E, Minner B, Vandervorst C, Raus J (1991): HPA-axis hormones and prolactin responses to dextro-fenfluramine in depressed patients and healthy controls. Prog Neuropsychopharmacol Biol Psychiatr 15:781-790
28. McBride A, Ierney H, DeMeo M, Chen J-S, Mann JJ (1990): Effects of age and gender on serotonergic responsivity in normal adults. Biol Psychiatr 27:1143-1155
29. Meltzer HY, Maes M (1994): Effects of buspirone on plasma prolactin and cortisol levels in major depression and normal subjects. Biol Psychiatry 35:316-323
30. Mitchell P, Smythe G (1990): Hormonal responses to fenfluramine in depressed and control subjects. J Affect Dis 19:43-51
31. Neilsen DA, Goldman D, Virkunnen M, Tokola R, Rawlings R, Linnoila M (1994): Suicidality and 5-hydroxyin-doleacetic acid concentration associated with a tryptophan hydroxylase polymorphism. Arch Gen Psychiatr 51:34-38
32. O'Keane V, Dinan TG (1991): Prolactin and cortisol responses to d-fenfluramine in major depression: Evidence for diminished responsivity of central serotonergic function. Am J Psychiatr 148:1009-1015
33. O'Keane V, O'Hanlon M, Webb M, Dinan TG (1991): d-Fenfluramine/prolactin response throughout the menstrual cycle: Evidence for an oestrogen-induced alteration. Clin Endocrinol 34:289-292
34. O'Keane V, McLoughlin D, Dinan T (1992): d-Fenfluramine induced prolactin and cortisol release in major depression: Response to treatment. J Affect Dis 26:143-150
35. 1A receptor involvement in the control of prolactin secretion in man. Psychopharmacology 119:311-314
36. Quattrone A, Tedeschi G, Aguglia U, Scopacasa F, Di Renzo GF, Annunziato L (1983): Prolactin secretion in man: A useful tool to evaluate the activity of drugs acting on central 5-hydroxytryptaminergic neurones. Studies with fenfluramine. Br J Clin Pharmacol 16:471-475
37. Rattle SJ, Purnell DR, Williams PIM, Siddle K, Forrest GC (1984): New separation method for monoclonal immunoradiometric assays for thyrotropin and human choriogonadotropin. Clin Chem 30:1457-1461
38. Roy A, Linnoila M (1988): Suicidal behavior, impulsiveness and serotonin. Acta Psychiatr Scand 78:529-535
39. Siever LJ, Murphy DL, Slater S, De La Vega E, Lipper S (1984): Plasma prolactin changes following fenfluramine in depressed patients compared to controls: An evaluation of central serotonergic responsivity in depression. Life Sci 34:1029-1039
40. Thakore J, Dinan TG (1995): Cortisol synthesis inhibition: A new treatment strategy for clinical and endocrine manifestations of depression. Biol Psychiatr 37:364-368
41. Van de Kar LD, Karteszi M, Bethea CL, Ganong WF (1985): Serotonergic stimulation of prolactin and corticosterone secretion is mediated by different pathways from the mediobasal hypothalamus. Neuroendocrinology 41:380-384
42. Van Praag HM, Lemus C, Kahn R (1986): Hormonal probes of central serotonergic activity: Do they really exist? Biol Psychiatr 22:86-98
43. Weizman A, Mark M, Gil-Ad I, Tyano S, Laron Z (1988): Plasma cortisol, prolactin, growth hormone, and immunoreactive beta-endorphin response to fenfluramine challenge in depressed patients. Clin Neuropharmacol 11: 250-256